In the News

Mar 9, 2018
Voyager’s gene therapy for Parkinson’s shows promise in early data from small Phase Ib trial

Feb 20, 2018
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy

Feb 7, 2018
The Intriguing Origins Of A Gene Therapy Biopharma
Life Science Leader

Oct 9, 2017
Where does Alzheimer’s R&D Go Now? Plenty of Directions
Timmerman Report

Sep 6, 2017
Voyager Therapeutics gene therapy improves motor function in Parkinson’s patients

Sep 6, 2017
Voyager Therapeutics adds proof its gene therapy for Parkinson’s can work, shares soar
Endpoints News

Mar 29, 2017
Drug industry looks for new ways to solve the Alzheimer's conundrum

Dec 7, 2016
Voyager Gene Therapy Shows Early, Promising Motor Function Improvements for Parkinson's Patients

Nov 21, 2016
Best Places to Work: Voyager Therapeutics
The Boston Globe

Nov 2016
Voyager Therapeutics Profile: Optimizing gene therapy for severe central nervous system diseases
Nature Biopharma Dealmakers

Aug 22, 2016
Manufacturing Dopamine in the Brain with Gene Therapy
MIT Technology Review

Jun 24, 2016
Best Places to Work: Voyager Therapeutics
Boston Business Journal

Apr 28, 2016
Gene Therapy Might Be the Best, and Perhaps Only, Chance at Curing Brain Diseases

Apr 26, 2016
Lessons from the biotech trenches: How to jump from an industry titan to running a drug startup

April 13, 2015
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers

Apr 13, 2015
Big Pharma partner: Check. Crossover round: Check. Hot tech: Check IPO…

Mar 13, 2015
Gene Therapy’s Breakout Moment
Boston Business Journal

Mar 2, 2015
The Coming Boom in Brain Medicines

Feb 12, 2015
Voyager, Sanofi team up on genetic treatments
The Boston Globe

Feb 11, 2015
Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager

Sep 22, 2014
Voyager sets out to change the game in gene therapy

Sep 3, 2014
Steven Paul, Former Lilly R&D Chief, Takes Head Seat at Voyager

May 4, 2014
CNN 10 Healing the Future: Ideas That Can Save Lives

Feb 13, 2014
New firm Voyager to use viruses to attack diseases
The Boston Globe